India cuts prices of 543 cancer drug brands, some by over 90%

Guwahati: India’s national drug price regulator has revised the maximum retail prices of 543 cancer drug brands, with some medicines becoming cheaper by more than 90%. The National Pharmaceutical Pricing Authority (NPPA) released the revised price list on Wednesday, covering several generic and bio…
Read the full story on Northeast Now Opens nenow.in in a new tab
Advertisement
OZYNIXCRM, HRMS & Business ToolsAI-powered business software — early access openContact us
This is a short summary of a story published by Northeast Now, shown with a link to the original. The full story, photo and reporting belong to Northeast Now.


















